1297 related articles for article (PubMed ID: 6189909)
21. Natural cytotoxicity of human blood lymphocytes and monocytes and their cytotoxic factors: effect of interferon on target cell susceptibility.
Uchida A; Vánky F; Klein E
J Natl Cancer Inst; 1985 Nov; 75(5):849-57. PubMed ID: 2414505
[TBL] [Abstract][Full Text] [Related]
22. Impaired release of natural killer cytotoxic factor in patients with primary Sjögren's syndrome.
Pedersen BK; Oxholm P
Clin Exp Immunol; 1988 May; 72(2):299-302. PubMed ID: 3409548
[TBL] [Abstract][Full Text] [Related]
23. Human natural killer cytotoxic factor. Studies on its production, specificity, and mechanism of interaction with target cells.
Blanca I; Herberman RB; Ortaldo JR
Nat Immun Cell Growth Regul; 1985; 4(1):48-59. PubMed ID: 4033671
[TBL] [Abstract][Full Text] [Related]
24. Studies on the mechanism of natural killer cell-mediated cytotoxicity. VI. Characterization of human, rat, and murine natural killer cytotoxic factors.
Wright SC; Wilbur SM; Bonavida B
Nat Immun Cell Growth Regul; 1985; 4(4):202-20. PubMed ID: 2999581
[TBL] [Abstract][Full Text] [Related]
25. H-2 antigen expression and sensitivity of BL6 melanoma cells to natural killer cell cytotoxicity.
Gorelik E; Gunji Y; Herberman RB
J Immunol; 1988 Mar; 140(6):2096-102. PubMed ID: 3126240
[TBL] [Abstract][Full Text] [Related]
26. Studies on the mechanism of natural killer (NK) cell-mediated cytotoxicity (CMC). I. Release of cytotoxic factors specific for NK-sensitive target cells (NKCF) during co-culture of NK effector cells with NK target cells.
Wright SC; Bonavida B
J Immunol; 1982 Jul; 129(1):433-9. PubMed ID: 7086139
[No Abstract] [Full Text] [Related]
27. Differences in target cell DNA fragmentation induced by mouse cytotoxic T lymphocytes and natural killer cells.
Duke RC; Cohen JJ; Chervenak R
J Immunol; 1986 Sep; 137(5):1442-7. PubMed ID: 2943792
[TBL] [Abstract][Full Text] [Related]
28. Induction of NKCF-like activity in mixed lymphocyte-tumor cell culture: direct involvement of mycoplasma infection of tumor cells.
Wayner EA; Brooks CG
J Immunol; 1984 Apr; 132(4):2135-42. PubMed ID: 6230401
[TBL] [Abstract][Full Text] [Related]
29. Analysis of cytostatic/cytotoxic lymphokines: relationship of natural killer cytotoxic factor to recombinant lymphotoxin, recombinant tumor necrosis factor, and leukoregulin.
Ortaldo JR; Ransom JR; Sayers TJ; Herberman RB
J Immunol; 1986 Nov; 137(9):2857-63. PubMed ID: 3093586
[TBL] [Abstract][Full Text] [Related]
30. Effect of altered membrane structure on NK cell-mediated cytotoxicity. II. Conversion of NK-resistant tumor cells into NK-sensitive targets upon fusion with liposomes containing NK-sensitive membranes.
Roozemond RC; van der Geer P; Bonavida B
J Immunol; 1986 May; 136(10):3921-9. PubMed ID: 3701064
[TBL] [Abstract][Full Text] [Related]
31. Sequential substages of natural killer cell-derived cytolytic factor (NKCF)-mediated cytolysis as defined by glutaraldehyde modulation of the target cell.
Deem RL; Targan SR
J Immunol; 1984 Oct; 133(4):1836-40. PubMed ID: 6432901
[TBL] [Abstract][Full Text] [Related]
32. Dual effects of cytokines in regulation of MHC-unrestricted cell mediated cytotoxicity.
Reiter Z
Crit Rev Immunol; 1993; 13(1):1-34. PubMed ID: 8466640
[TBL] [Abstract][Full Text] [Related]
33. Enhanced lysis of herpes simplex virus type 1-infected mouse cell lines by NC and NK effectors.
Colmenares C; Lopez C
J Immunol; 1986 May; 136(9):3473-80. PubMed ID: 2420891
[TBL] [Abstract][Full Text] [Related]
34. Lysis of natural killer-sensitive and -resistant tumor cells by natural killer cytotoxic factors (NKCF)-containing liposomes.
Roozemond RC; Urli DC; Wright SC; Graves SS; Bonavida B
Immunobiology; 1987 Dec; 176(1-2):35-46. PubMed ID: 3447981
[TBL] [Abstract][Full Text] [Related]
35. Role of interferon in human natural killer activity against target cells infected with HSV-1.
Bishop GA; Glorioso JC; Schwartz SA
J Immunol; 1983 Oct; 131(4):1849-53. PubMed ID: 6194217
[TBL] [Abstract][Full Text] [Related]
36. Natural killer cell immunodeficiency in patients with chronic myelogenous leukemia. IV. Interleukin-1 deficiency, gamma-interferon deficiency and the restorative effects of short-term culture in the presence of interleukin-2 on natural killer cytotoxicity, natural killer-target binding and production of natural killer cytotoxic factor.
Chang WC; Hsiao MH; Pattengale PK
Nat Immun Cell Growth Regul; 1991; 10(2):57-70. PubMed ID: 1881400
[TBL] [Abstract][Full Text] [Related]
37. Enhancement of susceptibility of HSV-1-infected cells to natural killer lysis by interferon.
Muñoz A; Carrasco L; Fresno M
J Immunol; 1983 Aug; 131(2):783-7. PubMed ID: 6190939
[TBL] [Abstract][Full Text] [Related]
38. Evidence of a dynamic role of the target cell membrane during the early stages of the natural killer cell lethal hit.
Deem RL; Targan SR
J Immunol; 1984 Jul; 133(1):72-7. PubMed ID: 6427347
[TBL] [Abstract][Full Text] [Related]
39. Target-effector interactions in the rat NK cell system. II. Effects of interferon on lytic efficiency and on pre-NK cells in various organs, rat strains and during ontogeny.
Flexman JP; Shellam GR
Clin Exp Immunol; 1984 Jan; 55(1):229-38. PubMed ID: 6198116
[TBL] [Abstract][Full Text] [Related]
40. Distinction of partially purified human natural killer cytotoxic factor from recombinant human tumor necrosis factor and recombinant human lymphotoxin.
Bialas T; Kolitz J; Levi E; Polivka A; Oez S; Miller G; Welte K
Cancer Res; 1988 Feb; 48(4):891-8. PubMed ID: 3257413
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
